title: Circulating concentrations of glucagon-like peptide 1, glucose-dependent insulinotropic peptide, peptide YY, and insulin in client-owned lean, overweight, and diabetic cats.
abstract: Our objectives were to measure plasma concentrations of glucagon-like peptide 1 (GLP-1), glucose-dependent insulinotropic peptide (GIP), and peptide YY (PYY) in client-owned newly diagnosed diabetic cats and nondiabetic lean or overweight cats and to determine whether circulating concentrations of these hormones differed between study groups and if they increased postprandially as seen in other species. A total of 31 cats were recruited and placed into 1 of 3 study groups: lean (body condition score 4-5 on a scale of 1-9; n = 10), overweight (body condition score 6-8; n = 11), or diabetic (n = 10). Diabetics were newly diagnosed and had not had prior insulin therapy. Preprandial (fasting) and postprandial (60 min after meal) plasma hormone and glucose concentrations were measured at baseline and 2 and 4 wk. All cats were exclusively fed a commercially available high-protein and low-carbohydrate diet commonly prescribed to feline diabetic patients for 2 wk before the 2-wk assessment and continued through the 4-wk assessment. Results showed that plasma concentrations of GLP-1, GIP, PYY, and insulin increased in general after a meal in all study groups. Plasma PYY concentrations did not differ (P > 0.10) between study groups. Diabetics had greater plasma concentrations of GLP-1 and GIP compared with the other study groups at baseline (P < 0.05), and greater preprandial and postprandial GLP-1 concentrations than lean cats at 2 and 4 wk (P < 0.05). Preprandial plasma GIP concentrations were greater in diabetics than obese and lean (P < 0.05) cats at week 4. Postprandial plasma GIP concentrations in diabetics were greater than lean (P < 0.05) at week 2 and obese and lean cats (P < 0.05) at week 4. Together, our findings suggest that diabetic status is an important determinant of circulating concentrations of GLP-1 and GIP, but not PYY, in cats. The role of GLP-1, GIP, and PYY in the pathophysiology of feline obesity and diabetes remains to be determined.
authors.affiliation: Department of Veterinary Clinical and Diagnostic Sciences, University of Calgary Veterinary Medicine, Calgary, Canada. Electronic address: cjmcmill@ucalgary.ca.
authors.forename: C J
authors.initials: CJ
authors.lastname: McMillan
authors.affiliation: Department of Production Animal Health, University of Calgary Veterinary Medicine, Calgary, Canada.
authors.forename: R C
authors.initials: RC
authors.lastname: Zapata
authors.affiliation: Department of Production Animal Health, University of Calgary Veterinary Medicine, Calgary, Canada.
authors.forename: P K
authors.initials: PK
authors.lastname: Chelikani
authors.affiliation: Department of Small Animal Clinical Sciences, Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon, Canada.
authors.forename: E C R
authors.initials: EC
authors.lastname: Snead
authors.affiliation: Western Veterinary Specialists and Emergency Centre, Calgary, Canada.
authors.forename: K
authors.initials: K
authors.lastname: Cosford
mesh_terms: D000818:Animals; D002371:Cat Diseases / Q000097:blood*; D002415:Cats; D003920:Diabetes Mellitus / Q000097:blood / Q000662:veterinary*; D005215:Fasting; D005749:Gastric Inhibitory Polypeptide / Q000097:blood*; D052216:Glucagon-Like Peptide 1 / Q000097:blood*; D007328:Insulin / Q000097:blood*; D009765:Obesity / Q000097:blood / Q000662:veterinary; D050177:Overweight / Q000097:blood / Q000662:veterinary; D019894:Peptide YY / Q000097:blood*; D019518:Postprandial Period
chemical_list: D007328:Insulin; D019894:Peptide YY; D005749:Gastric Inhibitory Polypeptide; D052216:Glucagon-Like Peptide 1
keywords: Diabetes; Enteroendocrine hormone; Feline